Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.
about
Cardiovascular risk in rheumatoid arthritis: assessment, management and next stepsMetabolic syndrome in rheumatoid arthritisEffects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-AnalysisA critical view on cardiovascular risk in systemic sclerosis.Influence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis.Rheumatoid arthritis in 2012: Progress in RA genetics, pathology and therapy.Lipid and Metabolic Changes in Rheumatoid Arthritis.Cardiovascular comorbidity in rheumatic diseases.Cardiovascular risk in patients with rheumatoid arthritis.Body mass index and response to abatacept in rheumatoid arthritis.Ang II-salt hypertension depends on neuronal activity in the hypothalamic paraventricular nucleus but not on local actions of tumor necrosis factor-α.Rheumatoid arthritis: Testing the inflammation-insulin resistance link in clinical trials.Aging, Obesity, and Inflammatory Age-Related Diseases.Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients.Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease.
P2860
Q26744334-94E923D2-DC3D-4C84-97B9-01D292FCF5BFQ26822038-3BBD2772-53BA-4FDD-BAD3-3126A73FCE6BQ26825588-6E25E7CF-FE99-44F4-A40A-D538F04FE79AQ30249024-6862B945-FD91-4ACA-824F-834A1F229E7FQ37000208-4DE86D89-3F08-49CD-88D5-8932E811DC0CQ38072312-CB7FF4ED-BE41-4EBD-8E24-80263EEBFD29Q38554197-811C4B81-9D9B-4D28-B2F0-B664FD700E3DQ38568465-F64976C7-7A89-4BD8-9912-CBEDB05C10A4Q38813397-CCB8D77D-8A05-4E93-91D5-53E0DCB7390AQ39296233-CF96CA46-10DC-4B47-B87D-FC7B57C57E80Q42005488-7B6E28CD-54BA-48A0-885C-D9528C186239Q46139682-8EA9ECD5-3BC6-4B66-85FE-79B9067C6249Q47139877-6781876A-D1A7-4ADC-AD26-33D09A09839EQ48508157-6FB25640-9152-401C-ABE1-2FB95B544638Q48874324-4FD0752A-FD50-4BEE-B9E9-DD3849F7C9B2Q51244473-31C6D303-79F3-4128-9CC0-F076C3061574
P2860
Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Anti-tumour necrosis factor al ...... nts with rheumatoid arthritis.
@ast
Anti-tumour necrosis factor al ...... nts with rheumatoid arthritis.
@en
type
label
Anti-tumour necrosis factor al ...... nts with rheumatoid arthritis.
@ast
Anti-tumour necrosis factor al ...... nts with rheumatoid arthritis.
@en
prefLabel
Anti-tumour necrosis factor al ...... nts with rheumatoid arthritis.
@ast
Anti-tumour necrosis factor al ...... nts with rheumatoid arthritis.
@en
P2093
P2860
P50
P356
P1476
Anti-tumour necrosis factor al ...... ents with rheumatoid arthritis
@en
P2093
Giorgos S Metsios
Peter Nightingale
Vasileios F Panoulas
P2860
P2888
P356
10.1186/AR3900
P577
2012-07-05T00:00:00Z
P5875
P6179
1030358648